UNSPSC 51401502: Climazolam

This classification denotes a benzodiazepine with the molecular formula C18H13Cl2N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier O9KZB9HG1Y, chemically known as 8-chloro-6-(o-chlorophenyl)-1-methyl-4h-imidazo(1,5-a)(1,4)benzodiazepine but generally known as climazolam, which bears US NIH Compound Identifier 68790. European Medicines Agency schedules Climazolam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06661MIG.

UNSPSC 51401502 Climazolam, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The single recent opportunity posted under this code—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and safe drug deactivation systems for community health initiatives, not climazolam or related pharmaceutical compounds. The mismatch suggests either a data-entry error in the tagging system or a misalignment between the code's nominal scope and how it is being applied in practice by the county procurement office. State and local governments buying under this code designation are not readily visible in current solicitation activity.

Seminole County, Florida released IFB 60459723LAS on June 30, 2026, with a response deadline of July 26, 2023 (a date inconsistency in the source), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement is structured as a competitive invitation for bid with an initial two-year term and an optional one-year renewal. Vendors must provide electronic bids through the county's e-Procurement Portal, include all shipping and delivery costs in their proposals, maintain workers' compensation and commercial general liability insurance, and comply with drug-free workplace certification and E-Verify requirements. The contract may be funded through FEMA and subjects vendors to federal compliance obligations including the Clean Air Act and Federal Water Pollution Control Act. No explicit set-aside designations for disadvantaged enterprises are identified in the solicitation. Without additional recent opportunities under this code, geographic concentration and issuing-body patterns cannot be characterized.